Onyx Healthcare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	374.34	324.59	366.77	328.89	182.89
Short-Term Investments	1.66	-	-	-	-
Trading Asset Securities	6.49	7.26	11.39	7.21	10.13
Cash & Short-Term Investments	382.5	331.85	378.16	336.1	193.02
Cash Growth	15.26%	-12.25%	12.51%	74.13%	-51.49%
Accounts Receivable	159.87	188.48	192.13	265.33	205.52
Other Receivables	15.26	8.18	2.84	5.15	10.66
Receivables	175.13	196.66	194.97	270.48	216.17
Inventory	253.53	270.87	245.69	311.53	271.22
Prepaid Expenses	22.41	23.76	18.29	19.23	16.49
Other Current Assets	0.48	1.46	33.86	1.7	1.52
Total Current Assets	834.04	824.61	870.97	939.03	698.42
Property, Plant & Equipment	379.3	377.12	383.71	332.58	69
Long-Term Investments	917.49	877.18	767.6	661.13	630.06
Other Intangible Assets	0.57	1.61	3.52	5.59	4.59
Long-Term Deferred Tax Assets	20.63	23.51	20.24	25.02	18.99
Other Long-Term Assets	1.67	2.17	2.17	3.57	280.87
Total Assets	2,154	2,106	2,048	1,967	1,702
Accounts Payable	87.36	62.75	68.56	106.36	124.53
Accrued Expenses	-	53.04	62.98	60.17	50.83
Short-Term Debt	130	80	27	-	105
Current Portion of Long-Term Debt	18.15	10.61	10.48	10.38	10.74
Current Portion of Leases	5.9	3.76	2.84	5.75	10.51
Current Income Taxes Payable	2.1	9.2	43.38	46.95	18.85
Current Unearned Revenue	62.03	82.02	61.85	64.73	75.76
Other Current Liabilities	78.71	37.48	28.07	24.55	35.09
Total Current Liabilities	384.25	338.86	305.15	318.89	431.31
Long-Term Debt	113.12	123.95	134.5	144.91	155.04
Long-Term Leases	33	32.66	31.92	30.89	34.25
Long-Term Unearned Revenue	44.69	49.59	53.3	67.86	42.14
Long-Term Deferred Tax Liabilities	6.72	6.29	0.42	-	1.28
Other Long-Term Liabilities	1.81	2.09	2.36	3.48	3.15
Total Liabilities	583.59	553.44	527.66	566.02	667.17
Common Stock	390.71	386.28	335.16	332.61	302.61
Additional Paid-In Capital	758.65	717.77	708.8	679.47	462.67
Retained Earnings	414.48	460.85	497.8	413.69	310.51
Comprehensive Income & Other	6.27	-20.31	-30.17	-33.93	-49.9
Total Common Equity	1,570	1,545	1,512	1,392	1,026
Minority Interest	-	8.17	8.95	9.05	8.87
Shareholders' Equity	1,570	1,553	1,521	1,401	1,035
Total Liabilities & Equity	2,154	2,106	2,048	1,967	1,702
Total Debt	300.17	250.98	206.74	191.92	315.55
Net Cash (Debt)	82.33	80.87	171.42	144.18	-122.53
Net Cash Growth	1.80%	-52.82%	18.89%	-	-
Net Cash Per Share	2.11	2.08	4.43	3.83	-3.51
Filing Date Shares Outstanding	38.93	38.63	38.54	38.25	34.8
Total Common Shares Outstanding	38.93	38.63	38.54	38.25	34.8
Working Capital	449.79	485.74	565.81	620.14	267.11
Book Value Per Share	40.33	39.99	39.22	36.39	29.48
Tangible Book Value	1,570	1,543	1,508	1,386	1,021
Tangible Book Value Per Share	40.32	39.95	39.13	36.24	29.35
Land	-	267.18	267.18	229.66	-
Buildings	-	71.79	71.7	48.8	-
Machinery	-	126.4	120.32	112.86	106.05
Construction In Progress	-	-	0.34	1.73	-
Leasehold Improvements	-	20	22.06	20.7	20.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.